Zydus Lifesciences informs about press release

08 Nov 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated November 8, 2022, titled ‘Zydus receives final approval from the USFDA for Bisoprolol Fumarate and Hydrochlorothiazide Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

886.30 -19.70 (-2.17%)
16-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.55
Dr. Reddys Lab 1275.05
Cipla 1298.80
Zydus Lifesciences 886.30
Lupin 2290.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×